Evidence map›Paper›PMID 29568403›Full record

ArticleOncotarget2018

Exosomal microRNA profiling to identify hypoxia-related biomarkers in prostate cancer.

Gati K Panigrahi, Anand Ramteke, Diane Birks, Hamdy E Abouzeid Ali, Sujatha Venkataraman, Chapla Agarwal, Rajeev Vibhakar, Lance D Miller, Rajesh Agarwal, Zakaria Y Abd Elmageed and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. MicroRNA Dysregulation in Prostate Cancer.Pharmacogenomics and personalized medicine · 2022
    Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Gati K PanigrahiDepartment of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Anand RamtekeDepartment of Molecular Biology and Biotechnology, Tezpur University, Tezpur, Assam, India.
Diane BirksUniversity of Colorado Denver, Aurora, Colorado, USA.
Hamdy E Abouzeid AliDepartment of Pharmaceutical Sciences, Texas A&M Rangel College of Pharmacy, Kingsville, Texas, USA.
Sujatha VenkataramanUniversity of Colorado Denver, Aurora, Colorado, USA.
Chapla AgarwalUniversity of Colorado Denver, Aurora, Colorado, USA.
Rajeev VibhakarUniversity of Colorado Denver, Aurora, Colorado, USA.
Lance D MillerDepartment of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Rajesh AgarwalUniversity of Colorado Denver, Aurora, Colorado, USA.
Zakaria Y Abd ElmageedDepartment of Pharmaceutical Sciences, Texas A&M Rangel College of Pharmacy, Kingsville, Texas, USA.
Gagan DeepDepartment of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
University of Colorado Denver · USTexas A&M University – Kingsville · USWake Forest University · USAtrium Health Wake Forest Baptist · USTezpur University · IN

Funding

Wake Forest Clinical and Translational Science AwardUL1TR001420 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ARD, JAMY D, FOLEY, KRISTIE L · 2015 to 2023
$32.3M
Exosomes Promote Disease Aggressiveness in African American Prostate CancerR21CA199628 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI DEEP, GAGAN · 2015 to 2016
$571k
The role of exRNA in Health Disparity of Prostate CancerR21CA194750 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI ABD ELMAGEED, ZAKARIA · 2015 to 2016
$350k
NCATS NIH HHS UL1 TR001420NCI NIH HHS R21 CA194750NCI NIH HHS R21 CA199628
6 · The paper itself

Abstract

Hypoxia and expression of hypoxia-related biomarkers are associated with disease progression and treatment failure in prostate cancer (PCa). We have reported that exosomes (nanovesicles of 30-150 nm in diameter) secreted by human PCa cells under hypoxia promote invasiveness and stemness in naïve PCa cells. Here, we identified the unique microRNAs (miRNAs) loaded in exosomes secreted by PCa cells under hypoxia. Using TaqMan

Indexed as

biomarkersexosomeshypoxiamiRNAsprostate cancer

Identifiers

PMID29568403
PMCPMC5862624
OpenAlexW2792045221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.